Nimotop · DIN 02325926 · 30 mg · tablet
Limited Use, Reason for Use code 42, 43 requiredMarketed · checked November 20, 2026
StatusLimited Use, Reason for Use code 42, 43 required
Write on scriptone applicable Reason for Use code, 42 or 43 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 42, 43
Reason for Use code 42
As adjunctive therapy to improve the neurologic outcome following subarachnoid haemorrhage during the acute management period (within 4 days of haemorrhage).
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 43
As prophylaxis of ischemia if surgery is delayed.
Coverage limit:
LU Authorization Period: 1 year
No interchangeable product listed in the Ontario extract
Nimotop · DIN 02325926
Manufacturer: Laboratoire X.O; listing date 2011-10-25
Health Canada: Marketed since 2025-08-18 · brand NIMOTOP · ATC C08CA06 NIMODIPINE · form Tablet · route Oral · ingredients NIMODIPINE 30 MG · company Laboratoire x.0 · schedule Prescription
Nimotop: Formulary list price $10.30 per unit (the source does not state the unit; exact figure $10.3006). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02325926)
Source record
DIN 02325926: Nimotop
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 241200095; group id 368; item number 0859; lccId 00215; manufacturer id LXO
Source form: Tab; strength: 30mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $10.3006; ministry $10.3006
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02325926
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=81127
Shortage status: not checked (no credentials)